首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Novel Ser79Leu and Ser81Ile Substitutions in the Quinolone Resistance-Determining Regions of ParC Topoisomerase IV and GyrA DNA Gyrase Subunits from Recent Fluoroquinolone-Resistant Streptococcus pneumoniae Clinical Isolates
【2h】

Novel Ser79Leu and Ser81Ile Substitutions in the Quinolone Resistance-Determining Regions of ParC Topoisomerase IV and GyrA DNA Gyrase Subunits from Recent Fluoroquinolone-Resistant Streptococcus pneumoniae Clinical Isolates

机译:从最近的耐氟喹诺酮抗性肺炎链球菌临床分离株中ParC拓扑异构酶IV和GyrA DNA促旋酶亚基的喹诺酮耐药性决定区域中的新型Ser79Leu和Ser81Ile取代。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Resistance of Streptococcus pneumoniae to fluoroquinolones is caused predominantly by amino acid substitutions at positions Ser79 of ParC and Ser81 of GyrA to either Phe or Tyr encoded in the quinolone resistance-determining regions of the parC topoisomerase IV and gyrA DNA gyrase genes. Analysis of highly resistant clinical isolates identified novel second-step substitutions, Ser79Leu (ParC) and Ser81Ile (GyrA). To determine contributions of these new mutations to fluoroquinolone resistance either alone or in combination with other Ser79/81 alleles, the substitutions Ser79Leu/Phe/Tyr in ParC and Ser81Ile/Phe/Tyr in GyrA were introduced into the R6 background, resulting in 15 isogenic strains. Their level of fluoroquinolone resistance was determined by susceptibility testing for ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin, gemifloxacin, garenoxacin, and norfloxacin. Leu79 and Ile81 alone as well as 79/81Phe/Tyr substitutions did not contribute significantly to resistance, with fluoroquinolone MICs increasing two- to fourfold compared to wild type for all agents tested. Fluoroquinolone MICs for double transformants ParC Ser79Phe/Tyr/Leu-GyrA Ser81Phe/Tyr were uniformly increased by 8- to 64-fold regardless of pairs of amino acid substitutions. However, combinations including Ile81 conferred two- to fourfold-higher levels of resistance than did combinations including any other Ser81 GyrA substitution, thus demonstrating the differential effects of diverse amino acid substitutions at particular hotspots on fluoroquinolone MICs.
机译:肺炎链球菌对氟喹诺酮类药物的耐药性主要是由ParC拓扑异构酶IV和gyrA DNA旋涡酶基因的喹诺酮耐药性决定区中的Phe或Tyr编码的ParC的SerC和Ser81的Ser79和Ser81位置的氨基酸取代引起的。对高抗性临床分离株的分析确定了新的第二步替代物,Ser79Leu(ParC)和Ser81Ile(GyrA)。为了确定这些新突变单独或与其他Ser79 / 81等位基因结合对氟喹诺酮耐药性的贡献,将ParC中的Ser79Leu / Phe / Tyr和GyrA中的Ser81Ile / Phe / Tyr取代引入R6背景,导致15个同基因株。通过对环丙沙星,左氧氟沙星,莫西沙星,加替沙星,吉非沙星,加仑沙星和诺氟沙星的药敏试验确定其氟喹诺酮耐药水平。单独的Leu79和Ile81以及79 / 81Phe / Tyr取代对抗药性没有显着贡献,对于所有测试的药物,与野生型相比,氟喹诺酮类MIC增加了2到4倍。双转化子ParC Ser79Phe / Tyr / Leu-GyrA Ser81Phe / Tyr的氟喹诺酮MIC均匀增加了8到64倍,而与成对的氨基酸取代无关。但是,与包含任何其他Ser81 GyrA取代的组合相比,包含Ile81的组合所赋予的抗性水平高2至4倍,因此证明了在特定热点上,多种氨基酸取代对氟喹诺酮类MIC具有不同的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号